Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Rewriting Life

Eyelash Lengthener

Women who want longer lashes now have an alternative to messy mascara. Latisse, a version of a drug developed for glaucoma, was recently approved by the U.S. Food and Drug Administration to promote eyelash growth. Latisse is dabbed along the base of the eyelashes and must be applied daily, or its lash-­thickening effect will wear off. Available only by prescription, it has some potential side effects, including eye redness, itchy eyes, and discoloration of the eyelid.

Courtesy of Allergan

This story is part of our March/April 2009 Issue
See the rest of the issue
Subscribe

Product: Latisse

Cost: $120 for a 30-day supply

Source: www.latisse.com

Company: Allergan

Other products in this section:

180° Surveillance Camera

Volume-Limiting Headphones

3-D Webcam

Pill ID

Internet Car Radio

One-Touch Data Backup

Portable Power

Energy-Saving Insulation

AI is here. Will you lead or follow?
Join us at EmTech Digital 2019.

Register now
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    Print + Digital Magazine (6 bi-monthly issues)

    Unlimited online access including all articles, multimedia, and more

    The Download newsletter with top tech stories delivered daily to your inbox

    Technology Review PDF magazine archive, including articles, images, and covers dating back to 1899

    10% Discount to MIT Technology Review events and MIT Press

    Ad-free website experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.